We want to be your go-to partner for achieving sustainable success, so dont hesitate to book a free consultation with one of our experts today
Insert the needle into the retatrutide vial at an angle so the needle tip touches the glass wall
Unlike Oral Wegovy, Foundayo can be taken with or without food and with any beverage making it the most flexible oral GLP-1 option currently available
Maintenance therapy usually involves injections every two to three months
However, CMS clarified in a memo dated March 20, 2024, that anti-obesity medications that receive FDA approval for an additional medically accepted indication can be considered a Part D drug for that specific use. As of August 19, 2024, the only GLP-1 RA this applies to is Wegovy, which, in addition to its obesity indication, is also indicated to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight
Readers can review current FDA guidance on this distinction at FDA.gov